Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Comparison of Glycemic Excursion in Patients with New Onset Type 2 Diabetes Mellitus before and after Treatment with Repaglinide.

Hezarkhani S, Bonakdaran S, Rajabian R, Shahini N, Marjani A.

Open Biochem J. 2013;7:19-23. doi: 10.2174/1874091X01307010019. Epub 2013 Feb 22.

2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.

Culy CR, Jarvis B.

Drugs. 2001;61(11):1625-60. Review.

PMID:
11577798
4.
5.

Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review.

Johansen OE, Birkeland KI.

Am J Cardiovasc Drugs. 2007;7(5):319-35. Review.

PMID:
17953471
6.

Repaglinide: prandial glucose regulation in clinical practice.

Owens DR, McDougall A.

Diabetes Obes Metab. 2000 Mar;2 Suppl 1:S43-8. Review.

PMID:
11225759
7.

Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.

Owens DR.

Diabet Med. 1998;15 Suppl 4:S28-36. Review.

PMID:
9868989
8.

Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?

Nattrass M, Lauritzen T.

Int J Obes Relat Metab Disord. 2000 Sep;24 Suppl 3:S21-31. Review.

PMID:
11063281

Supplemental Content

Support Center